Elderly patients denied best treatment for fear of side effects
A study involving 83 elderly women found that patients with depression, limited autonomy, and institutional living are at risk of toxicity and reduced treatment effectiveness. Dr. Gilles Freyer's research aims to evaluate risks and benefits for elderly patients with advanced ovarian cancer.